Estrogen exerts neuroprotective effects on the brain, and the reduction in endogenous estrogen after menopause increases women’s risk for Alzheimer’s disease (AD), cerebrovascular disease, or both.

In the early 2000s I was called into a meeting at work that lasted two hours but changed my professional perspective on dementia care. At that meeting, our speaker was Naomi Feil. Mrs. Feil introduced ...

Menopausal hormone therapy was linked with dementia and Alzheimer's disease, even in women who received treatment at age 55 or younger, a large observational study in Denmark suggested. Women ages 50 ...

Use of menopausal hormone therapy is associated with an increased rate of dementia and Alzheimer's disease, suggests a large Danish study published by The BMJ today. An increase was seen in long term ...

Women taking hormone replacement therapy to ease symptoms of menopause might face an increased risk of dementia later in life, a new study indicates. Women who received estrogen-progestin therapy had ...

Nikki-Anne Wilson is affiliated with the University of New South Wales and Neuroscience Research Australia (NeuRA). She is also currently a contributor to the Ageing Advisory Committee facilitated by ...

Use of menopausal hormone therapy is associated with an increased rate of dementia and Alzheimer's disease, suggests a large Danish study published by The BMJ today. An increase was seen in long-term ...